Closed-Loop Anesthesia, Using Bispectral Index as the Control Variable, During Liver Transplantation (Drone-TH)

This study has been withdrawn prior to enrollment.
(lack of recrutment)
Sponsor:
Information provided by:
Hopital Foch
ClinicalTrials.gov Identifier:
NCT00477347
First received: May 21, 2007
Last updated: March 12, 2009
Last verified: March 2009

May 21, 2007
March 12, 2009
May 2007
September 2009   (final data collection date for primary outcome measure)
consumption of propofol during anesthesia maintenance [ Time Frame: during anesthesia maintenance ] [ Designated as safety issue: No ]
consumption of propofol during anesthesia maintenance [ Time Frame: during anesthesia maintenance ]
Complete list of historical versions of study NCT00477347 on ClinicalTrials.gov Archive Site
- consumption of remifentanil - target modifications - hemodynamic events - volume loading and transfusion - extubation time, explicit memorization - time passed at BIS between 40 and 60 - MDAPE, wobble - global score - dysfunction of each system. [ Time Frame: during anesthesia maintenance ] [ Designated as safety issue: No ]
- consumption of remifentanil - target modifications - hemodynamic events - volume loading and transfusion - extubation time, explicit memorization - time passed at BIS between 40 and 60 - MDAPE, wobble - global score - dysfunction of each system. [ Time Frame: during anesthesia maintenance ]
Not Provided
Not Provided
 
Closed-Loop Anesthesia, Using Bispectral Index as the Control Variable, During Liver Transplantation
Comparison of Manual Propofol and Remifentanil Administration and Dual Closed-Loop, Using Bispectral Index as the Control Variable, During Liver Transplantation

To compare closed-loop anesthesia to manual administration of propofol and remifentanil during liver transplantation

The Bispectral Index (BIS) is an electroencephalogram-derived measure of anesthetic depth. We hypothesized that BIS can also indicate the adequacy of analgesia. Therefore we built a combined closed-loop anesthesia system using BIS as control variable and two proportional-differential control algorithms, a propofol and a remifentanil target-controlled infusion system. The effectiveness of such a closed-loop anesthesia system has been demonstrated in a prospective, randomized study.

Elimination of anesthetic agents, propofol in particular, is strongly reduced during liver transplantation. Closed-loop anesthesia could provide adequacy for requirements in respect to the various phases of transplantation. Two groups of patients are compared: one in which propofol and remifentanil are administered by the anesthesiologist, using target-controlled infusion systems, and one in which propofol and remifentanil are administered automatically by the combined closed-loop anesthesia system. In both groups the goal is to maintain BIS between 40 and 60, the range recommended by the manufacturer during anesthesia. We expect the combined closed-loop anesthesia system group to do better: i.e. diminished consumption of propofol (primary outcome measure).

Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Liver Transplantation
  • Device: Closed loop administration
    intraoperative closed loop administration of propofol and remifentanil
    Other Name: closed-loop
  • Device: Manual administration
    intraoperative manual administration of propofol and remifentanil
    Other Name: target controlled anesthesia
  • Active Comparator: 1
    Manual administration
    Intervention: Device: Manual administration
  • Experimental: 2
    Closed-loop administration
    Intervention: Device: Closed loop administration

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
40
September 2009
September 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • liver transplantation

Exclusion Criteria:

  • pregnant women
  • allergy to propofol or remifentanil,
  • neurological or muscular disorder,
  • liver encephalopathy,
  • patients taking psychotropic agents
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00477347
2006/37
No
Marc Fischler, Hopital Foch
Hopital Foch
Not Provided
Principal Investigator: Marc Fischler, MD
Hopital Foch
March 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP